Search Within

Arnab Ghosh

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (1)
Groups
  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. Epidemiology and Biostatistics (6)
  4. Hematologic Malignancies, Division of (6)
  5. Weinberg Fellows (6)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (5)

More Groups

People
  1. Jedd Wolchok (3)
  2. Taha Merghoub (3)
  3. Andrew Chow (2)
  4. Benjamin Greenbaum (2)
  5. Divya Venkatesh (2)
  6. Levi Mark Mangarin (2)

More People

Years
  1. 2024 (1)
  2. 2022 (2)
  3. 2021 (1)
  4. 2016 (1)
  5. 2010 (1)
Publications
  1. Blood (1)
  2. Cell (1)
  3. Clinical Cancer Research (1)
  4. JNCI: Journal of the National Cancer Institute (1)
  5. Journal of Clinical Investigation (1)
  6. Science Translational Medicine (1)
Publishers
  1. American Association for Cancer Research (1)
  2. American Association for the Advancement of Science (1)
  3. American Society for Clinical Investigation (1)
  4. American Society of Hematology (1)
  5. Cell Press (1)
  6. Oxford University Press (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
    Journal Article

    Ghosh, A.; Michels, J.; Mezzadra, R.; Venkatesh, D.; Dong, L.; Gomez, R.; Samaan, F.; Ho, Y. J.; Campesato, L. F.; Mangarin, L.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
    Journal Article

    Gigoux, M.; HolmstroĢˆm, M. O.; Zappasodi, R.; Park, J. J.; Pourpe, S.; Bozkus, C. C.; Mangarin, L. M. B.; Redmond, D.; Verma, S.; Schad, S.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save
  • Pharmacologic modulation of RNA splicing enhances anti-tumor immunity
    Journal Article

    Lu, S. X.; De Neef, E.; Thomas, J. D.; Sabio, E.; Rousseau, B.; Gigoux, M.; Knorr, D. A.; Greenbaum, B.; Elhanati, Y.; Hogg, S. J.; more...
    Cell (2021)

    Fulltext@MSK | Save
  • TP53 mutations in AML predict adverse outcome in patients undergoing allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Getta, B. M.; Ghosh, A.; Coombs, C. C.; Devlin, S.; Arcila, M.; Mohanty, A.; Levine, R. L.; Tallman, M. S.; Jakubowski, A. A.; Giralt, S. A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth
    Journal Article

    Penack, O.; Henke, E.; Suh, D.; King, C. G.; Smith, O. M.; Na, I. K.; Holland, A. M.; Ghosh, A.; Lu, S. X.; Jenq, R. R.; more...
    JNCI: Journal of the National Cancer Institute (2010)

    Fulltext@MSK | Save